- Fourth Carcinogen DMF Found in Blood-Pressure Pill Valsartan - Bloomberg
- Chinese Heart Drug Valsartan Recall Shows FDA Inspection Limits - Bloomberg
- J&J knew for decades that asbestos lurked in its Baby Powder
- Pennsylvania Xarelto Bleeding Lawsuit Trials Begin Next Month
- Editorial: Fighting back against Big Pain, without much help from Congress | Editorial | stltoday.com
- Pennsylvania’s First Xarelto Lawsuit Trial Concludes With $28 Million Verdict for Plaintiff, Bernstein Liebhard LLP Reports | Life Pulse Health
- California Woman Files Celect® IVC Filter Lawsuit – Daily Hornet | Breaking News That Stings!
- Wright Medical Pays $90 Million to Settle Remaining Hip Lawsuits
- Filings Fly as Xarelto Mass Tort Prepares for Trial | Law.com
- Father blames NuvaRing manufacturers for daughter's death | St. Louis Record
FDA Must Turn Over 4,000 Documents Due To Whistleblowers
Scientists working for the U.S. Food and Drug Administration claim the agency spied on them illegally. In a court ruling, U.S. District Judge James Boasberg has ordered the FDA to immediately turn over 4,000 pages of material that the scientists requested. This ruling, in essence, speeds up the discovery phase of the trial. Additionally, remaining documents must be produced by September 10. All of these documents are in addition to ones that have already been released to the public.
The case started three years ago when it was discovered by the FDA that some researchers within the agency had contacted Barack Obama, President-elect at the time, with concerns about the process for approving medical devices. These employees criticized the procedures for approval, which they considered to be too lax.
Among the complaints, according the the lead attorney for the whistleblowers, Stephen Kohn, are 20 medical devices that could be exposing patients to dangers. For example, extremely high doses of radiation exuding from CT scanners and ultrasound machines may be exposing individuals to radiation levels that are 800 times higher than a chest X-ray, according to the lawsuit. Breast cancer detection devices were still approved by the FDA, even though the machines are not effective nor safe, per the researchers.
A serious concern arose from the employees when it was discovered that monitoring of their correspondence had begun, as well as monitoring of the interactions with each other on the job. Screenshots of individual computer screens were taken by the FDA. Gmail accounts were also under surveillance. Personal and private information that was stored on defendants’ computers was secretly obtained through these methods, it was learned. In addition, views of documents clearly marked for Congress were illegally obtained by the FDA through such spying, it is alleged.
In an inadvertent move, according to the contractor handling such government documents, much of the documented information was released on a public website earlier this month. It is estimated that there are possibly 80,000 pages of documentation regarding the surveillance activities. The researchers claim that their civil rights, such as unreasonable search and seizure, freedom of speech, and the right to petition Congress, have been violated. Kohn pointed out that monitoring done to every employee on a similar basis is not cause for a lawsuit. When monitoring is selectively done to individuals who are blowing the whistle, however, it is unacceptable.
Recent Posts
By Date
- June 2019
- February 2019
- January 2019
- March 2018
- February 2018
- January 2018
- November 2017
- October 2017
- September 2017
- August 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- December 2015
- November 2015
- August 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- January 2014